Le dépistage tardif de l’infection à VIH à l’ère du Tester et traiter : un frein pour l’optimisation du traitement antirétroviral
Résumé
Texte intégral :
PDFRéférences
Cain LE, Logan R. Robins JM. et al.
When to Initiate Combined
Antiretroviral Therapy to Reduce
Mortality and AIDS-Defining Illness
in HIV-Infected Persons in Developed
Countries: An Observational Study.
Annals of Internal Medicine 2011,
: 509-515
Cohen MS, Chen YQ, McCauley M et
al. Prevention of HIV-1 Infection
with Early Antiretroviral Therapy.
The New England Journal of
Medicine 2011, 365: 493-505
WHO Consolidated Guidelines on the
Use of Antiretroviral Drugs for
Treating and Preventing HIV
Infection: Recommendations for a
Public Health Approach. 2016
http://www.who.int/hiv/pub/arv/arv2016/en
UNAIDS 90-90-90: An Ambitious
Treatment Target to Help end the
AIDS Epidemic. 2014
http://www.unaids.org/sites/default/fi
les/media_asset/90-90-90_en_0.pdf
Conseil National de Lutte Contre le
Sida Au Sénégal : Rapport de
situation sur la riposte nationale à
l’épidémie du VIH/SIDA Sénégal.
: 60
Conseil National de Lutte Contre le
Sida au Sénégal. Plan national
stratégique de
lutte contre le VIH au Sénégal 2018-
80
Avila D, Althoff KN, Mugglin C and
al. Immunodeficiency at the start of
combination antiretroviral therapy in
low-, middle-, and high-income
countries in the IeDEA and ART
Cohort Collaborations: J Acquir
Immune Defic Syndr 2014; 65(1): 8-16
Drain PK, Losina E, Parker G and al.
Risk Factors for Late-Stage HIV
Disease Presentation at Initial HIV
Diagnosis in Durban, South Africa
PLoS One. 2013; 8(1): e55305
Mutimura E, Addison D, Anastos K
and al. Trends in and correlates of
CD4+ cell count at antiretroviral
therapy initiation after changes in
nation al ART guidelines in Rwanda
AIDS 2015; 29(1): 67-76
Conseil National de Lutte Contre le
Sida au Sénégal : Rapport taux de
survie 2020. 30
Manga NM, Diop SA, Ndour CT et
al. Dépistage tardif de l’infection à
VIH à la clinique des maladies
infectieuses de Fann, Dakar :
Circonstances de diagnostic,
itinéraire thérapeutique des patients
et facteurs déterminants. Médecine et
Maladies Infectieuses 2009, 39 : 95-
Ngom NF, Faye MA, Ndiaye K et al.
ART initiation in an outpatient
treatment center in Dakar, Senegal: A
retrospective cohort analysis (1998-
. PLoSONE 2018; 13(9):
e0202984
Ba S, Ba ND, Sembene L and al.
Prevalence and Factors Associated
with Virologic Failure among People
Living with HIV (PLHIV) Monitored
in a Decentralized Health Care
Facility. Advances in Infectious
Diseases, 2019, 9, 226-237
OMS (2007) Guide du conseil et du
dépistage du VIH à l’initiative du
soignant dans les établissements de
santé.http://www.who.int/publication
s/list/9789242595568/fr
Glencross DK, Cassim N, Coetzee
LM and al. Documented higher
burden of advanced and very
advanced HIV disease among
patients, especially men, accessing
healthcare in a rapidly growing
economic and industrial hub in South
Africa: A call to action S Afr Med
J 2020; 110(6): 505-513
Lippman SA, Lane T, Rabede O and
al. High Acceptability and Increased
HIV Testing Frequency Following
Introduction of HIV Self-Testing and
Network Distribution among South
African MSM: J Acquir Immune
Defic Syndr. 2018; 77(3): 279-287
Lian Y, Zhao Y, Wang J and al. A
health communication intervention to
integrate partner testing with
antiretroviral therapy service among
men who have sex with men in China:
an observational cohort study Lian et
al. BMC Public Health. 2018 ; 18: 12-
Lillie TA, Persaud NE, DiCarlo MC
and al. Reaching the unreached:
Performance of an enhanced peer
outreach approach to identify new
HIV cases among female sex workers
and men who have sex with men in
HIV programs in West and Central
Africa. PLoS One. 2019; 14(4):
WHO. Updated Recommendations
on First-Line and Second-Line
Antiretroviral Regimens and PostExposure Prophylaxis and
Recommendations on Early Infant
Diagnosis of HIV: Interim Guidance.
World Health Organization, Geneva.
Seifu W, Ali W, Meresa B and al.
Predictors of Loss to Follow Up
among Adult Clients Attending at
Karamara General Hospital, Jigjiga
Town, Eastern Ethiopia, 2015: A
Retrospective Study. BMC Infectious
Diseases, 2018. 18: 280
The Lancet U=U. Taking off in 2017,
: 475
Grarup J, Rappoport C, Engen NW
et al. Challenges, Successes and
Patterns of Enrolment in the Insight
Strategic Timing of Anti-Retroviral
Treatment (START) Trial. HIV
Medicine 2015, 16, 14-23
Renvois
- Il n'y a présentement aucun renvoi.